Related Experiment Video

Updated: Oct 8, 2025

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.1K

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy

Tracey M Ellimuttil1, Kimberly Harrison1,2, Allman T Rollins2,3

  • 1Department of Pharmacy, Vanderbilt University Medical Center Nashville, TN, US.

Cardiac Failure Review
|December 24, 2021
PubMed

Insights

Statin intensity did not significantly impact the time to cardiac allograft vasculopathy (CAV) in heart transplant recipients. Higher intensity statins may not offer additional long-term clinical benefits for preventing CAV.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Pharmacology

Background:

  • Hyperlipidemia management in non-transplant patients shifted to statin intensity.
  • The benefit of statin intensity in cardiac transplant recipients remains unclear.
  • Cardiac allograft vasculopathy (CAV) is a major concern post-heart transplant.

Purpose of the Study:

  • To evaluate the effect of statin use and intensity on the time to CAV.
  • To determine if statin intensity influences CAV-free survival after cardiac transplantation.

Main Methods:

  • Single-center retrospective study of 143 adult cardiac transplant recipients (2013-2017).
  • Kaplan-Meier and Cox regression analyses assessed statin intensity and low-density lipoprotein (LDL) on CAV-free survival.
  • Follow-up averaged 25 ± 14 months.

Main Results:

  • Mean CAV-free survival was 47.5 months; 29 patients developed CAV grade ≥1.
  • Median LDL levels showed no association with time to CAV (p=0.790).
  • CAV-free survival did not differ significantly between statin intensity groups (p=0.435).

Conclusions:

  • Statin intensity did not demonstrate a statistically significant impact on time to CAV.
  • Current data suggest that escalating to moderate- or high-intensity statins post-transplant may not confer additional long-term clinical benefit for CAV prevention.

Keywords:
3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitorCoronary allograft vasculopathyheart transplantation complication

More Related Videos

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

8.6K
Mouse Models for Graft Arteriosclerosis07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

13.8K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
938
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
62
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60